|
|
 |
|
Viewing report
|
|
|
|
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
La Merie, Jan 2011, Pages: 35
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of January 2011 provides a competitor analysis in the development pipeline of novel recombinant, transgenic and oral FSH, hCG and LH receptor agonists for treatment of infertility.
The report describes the market size of major FSH products, provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
- additional comments with a hyperlink leading to the source of information.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
Competitor Analysis: Follicle Stimulating Hormone (FSH)
Competitor Analysis: Biogenerics & Therapeutic Proteins
Competitor Analysis: Targeted Therapy of Diabetes
Competitor Analysis: Diabetes Drug Pipeline
Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins
Women's Infertility - Pipeline Assessment and Market Forecasts to 2017
Competitor Analysis: Insulin
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects
|
|
|
|
